Actually, it is still quite difficult to understand why the exenatide-based drugs are not really showing a cardiovascular benefit, because they arent but thats a different matter
Epidermal surface lipids
Expanded Indications for GLP-1 Receptor Agonists The 2025 American Diabetes Association (ADA) Standards of Care have broadened the use of GLP-1 receptor agonists beyond glycemic control
Ingredients: PHYTOSTERYL/ISOSTEARYL/CETYL/STEARYL/BEHENYL DIMER DILINOLEATE, DIISOSTEARYL MALATE, HYDROGENATED POLYISOBUTENE, BUTYROSPERMUM PARKII (SHEA) BUTTER, TRIBEHENIN, SYNTHETIC WAX, 1,2-HEXANEDIOL, MICROCRYSTALLINE WAX/CIRE MICROCRISTALLINE, SYNTHETIC FLUORPHLOGOPITE, ETHYLENE/PROPYLENE COPOLYMER, SIMETHICONE, ASCORBIC ACID, ASCORBYL GLUCOSIDE, NIACINAMIDE, PANTHENOL, FRAGRANCE/PARFUME, LIMONENE, LINALOOL, CITRAL, RED 7 LAKE(CI 15850), YELLOW 5 LAKE(CI 19140), TITANIUM DIOXIDE(CI 77891)
Important Note: While many patients experience these benefits, complete scientific validation is still ongoing